New figures released this month by the Turkish Statistics Institute show that Turkey’s domestic R&D grew 20.4% in 2011 to TRY 11,154 million ($6,374 million = TRY 1.75 = $1), following a 14.6% increase in 2010. Labor, “other current costs” (non-capital materials and supplies, administrative costs, indirect service), instruments and equipment, and land and buildings […]

For some of the acquisition reported in IBO over the last year, purchase prices were not available at the time of the announcement. The table below shows the prices for acquired companies that were later disclosed in regulatory filings or company reports. Bio-Rad Laboratories also disclosed in its third-quarter regulatory filing that it paid $5 […]

Despite weak academic and government spending, third-quarter IBO Laboratory Sales Index grew 1.2%, 3.8% excluding currency, to $5,839 million. Operating profit improved 1.4% to $1,165 million. Based on continuing operations, operating margin was unchanged at 18.8% of sales. For the three companies that did not report earnings before this issue’s publication (Agilent Technologies, Spectris and […]

Much of the focus for analytical instrument sales in Asia has been on China and India. However, other areas in Asia Pacific, particularly continental Southeast Asia, which is comprised of Cambodia, Laos, Malaysia, Myanmar, Singapore, Thailand and Vietnam, exhibit strong growth opportunities. Sales of analytical instrumentation (see box, page 8) in Asia Pacific grew more […]

After several years of sizable transactions, merger and acquisition (M&A) activity in the instrument and laboratory product–related industry was restrained in 2012. The combined value of the top five largest pure-play acquisitions amounted to $2.2 billion in 2012, compared with an average of $7.2 billion over the previous five years. However, the absence of any […]

Next spring, Carl Zeiss will begin shipping its Lightsheet Z.1 Light Sheet Microscope System, which was introduced this month at the Society for Neuroscience Annual Meeting. The original light sheet microscopy technology the System is based on was introduced by Carl Zeiss in the 1900s and has been adapted for three-dimensional fluorescence imaging in biology. […]

Choppy third-quarter corporate earnings along with a generally cautious outlook led the Dow Jones Industrial Average, S&P 500 and NASDAQ down 2.5%, 2.0% and 4.5% in October, respectively. However, other economic data, including better-than-expected new home sales and jobless claims, indicated improved financial conditions. Third-quarter GDP growth, while still tepid at 2.0%, improved from the […]

In this issue, IBO presents its second look this year at patent infringement litigation involving lab instrument and product companies. New Suits Legal activity has heightened between Illumina and sequencing services provider Complete Genomics. In June, Illumina filed a second patent infringement suit against publicly held Complete Genomics, which is set to be acquired by […]

According to the results of IBO’s Fall 2012 Business Climate Survey, expectations for near-term instrument and laboratory product sales have hit their lowest point since spring 2009 (see graph, page 6). Twenty-four percent of respondents expect instrument and lab product sales to decline industry wide over the calendar-year fourth quarter 2012 and first quarter 2013. […]